Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Insightec pulls in $22m, taps board chair Ferré as CEO
Insightec said it secured a $22 million investment and tapped Dr. Maurice Ferré, the former chief at Mako Surgical, as its new CEO, as founder Kobi Vortman steps down for a seat on the board.
The $22 million comes from a current stakeholder as part of a Series D round of financing, the Israeli company said. Read more
2. Sientra soars after independent panel OKs breast implants
Shares of Sientra, which hit a 52-week low last year after regulators shut down production at its sole supplier, soared after new CEO Jeffrey Nugent said independent testing found its breast implants safe for implantation.
Santa Barbara, Calif.-based Sientra tapped Nugent shortly after Brazilian regulator Anvisa suspended production at Silimed, Sientra’s supplier, and the U.K.’s Medicines & Healthcare Products Regulatory Agency halted sales. Read more
1. Bard to shutter ex-Rochester Medical plants in Minnesota, laying off 185
C.R. Bard reportedly plans to shutter a trio of Bard Medical plants in Minnesota by the end of the year, meaning layoffs for the 185 workers employed there.
“We understand that our employees are directly impacted by this decision. We are committed to treating them fairly and will respect, and we will support them during this transition,” Bard said. Read more
The post MassDevice.com +3 | The top 3 medtech stories for January 8, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/1PTy1Nx
Cap comentari:
Publica un comentari a l'entrada